Conditions: Chronic Obstructive Pulmonary Disease
Keywords: Chronic Obstructive Pulmonary Disease COPD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 613
Healthy volunteers: no

Brief summary:
The purpose of this study is to show the efficacy and safety of formoterol for the maintenance treatment of patients with COPD compared with placebo in patients in Japan and in European countries during 12 weeks.

Detailed description:

Arms:
arm 1: Formoterol 4.5 ug twice daily (bid) arm 2: Formoterol 9.0 ug bid arm 3: Placebo

Interventions: intervention 1: Formoterol Turbuhaler® 4.5mg intervention 2: Formoterol Turbuhaler® 9 mg intervention 3: Turbuhaler® placebo
Intervention descriptions: intervention 1: 4.5 mg inhaled twice daily intervention 2: 9 mg inhaled twice daily intervention 3: placebo inhaled twice daily

Protocol document: